Retrospective Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Dec 14, 2020; 26(46): 7382-7404
Published online Dec 14, 2020. doi: 10.3748/wjg.v26.i46.7382
Table 3 Correlation between preoperative plasma albumin level and clinicopathological characteristics in pancreatic ductal adenocarcinoma patients who underwent R0 resection, n (%)
Characteristics
Preoperative plasma albumin level
P value
> 45.2 g/L, n = 85
≤ 45.2 g/L, n = 197
Age in yr0.602
> 6042 (14.9)104 (36.9)
≤ 6043 (15.2)93 (33.0)
Sex0.699
Male47 (16.7)104 (36.9)
Female38 (13.5)93 (33.0)
Clinical symptoms0.012
Absent25 (8.9)32 (11.3)
Present60 (21.3)165 (58.5)
Diabetes0.458
Absent58 (20.6)143 (50.7)
Present27 (9.6)54 (19.1)
Smoking status0.806
Absent64 (22.7)151 (53.5)
Present21 (7.4)46 (16.3)
Alcohol consumption0.523
Absent69 (24.5)166 (58.9)
Present16 (5.7)31 (11.0)
Family history of cancer0.832
Absent82 (29.1)189 (67.0)
Present3 (1.1)8 (2.8)
Blood type0.169
A33 (11.7)54 (19.1)
B22 (7.8)71 (25.2)
AB8 (2.8)14 (5.0)
O22 (7.8)58 (20.6)
Tumor location< 0.001
Head and neck24 (8.5)106 (37.6)
Body and tail61 (21.6)91 (32.3)
Approaches of open surgery< 0.001
Pancreaticoduodenectomy24 (8.5)106 (37.6)
Distal pancreatectomy with splenectomy61 (21.6)91 (32.3)
Degree of differentiation0.567
Well8 (2.8)26 (9.2)
Moderately66 (23.4)151 (53.5)
Poorly11 (3.9)20 (7.1)
Lymphovascular invasion0.814
Absent62 (22.0)141 (50.0)
Present23 (8.2)56 (19.9)
Perineural invasion0.741
Absent20 (7.1)50 (17.7)
Present65 (23.0)147 (52.1)
Capsular invasion0.673
Absent16 (5.7)33 (11.7)
Present69 (24.5)164 (58.2)
Maximum tumor diameter in cm0.330
> 430 (10.6)58 (20.6)
≤ 455 (19.5)139 (49.3)
T stage0.530
T18 (2.8)26 (9.2)
T247 (16.7)112 (39.7)
T330 (10.6)59 (20.9)
Number of metastatic lymph nodes0.363
Absent52 (18.4)109 (38.7)
Present33 (11.7)88 (31.2)
N stage0.127
N052 (18.4)109 (38.7)
N129 (10.3)63 (22.3)
N24 (1.4)25 (8.9)
TNM stage0.145
IA4 (1.4)16 (5.7)
IB34 (12.1)58 (20.6)
IIA14 (5.0)35 (12.4)
IIB29 (10.3)63 (22.3)
III4 (1.4)25 (8.9)
Adjuvant therapy0.003
Absent26 (9.2)98 (34.8)
Present59 (20.9)99 (35.1)
Preoperative CA19-9 level in U/mL0.416
> 336.426 (9.2)51 (18.1)
≤ 336.459 (20.9)146 (51.8)
Preoperative plasma fibrinogen concentration in g/L0.006
> 3.3132 (11.3)109 (38.7)
≤ 3.3153 (18.8)88 (31.2)
Preoperative FAR< 0.001
> 0.0815 (5.3)111 (39.4)
≤ 0.0870 (24.8)86 (30.5)